Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity
Authors
Keywords
-
Journal
Biomolecules & Therapeutics
Volume 22, Issue 5, Pages 414-419
Publisher
The Korean Society of Applied Pharmacology
Online
2014-11-06
DOI
10.4062/biomolther.2014.099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Matrix metalloproteinase inhibitors: a patent review (2011 – 2013)
- (2014) Nian-Guang Li et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Matrix Metalloproteinase-8 Plays a Pivotal Role in Neuroinflammation by Modulating TNF-α Activation
- (2014) Eun-Jung Lee et al. JOURNAL OF IMMUNOLOGY
- Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview
- (2013) Mohammad A. Javaid et al. ACTA NEUROLOGICA BELGICA
- Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system
- (2013) Mieke Verslegers et al. PROGRESS IN NEUROBIOLOGY
- Discovery of Novel Inhibitors of a Disintegrin and Metalloprotease 17 (ADAM17) Using Glycosylated and Non-glycosylated Substrates
- (2012) Dmitriy Minond et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases
- (2012) Li Tian et al. Journal of Neuroinflammation
- Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
- (2010) Anna Morancho et al. Annals of the New York Academy of Sciences
- Tumor Necrosis Factor Alpha Converting Enzyme: An Encouraging Target for Various Inflammatory Disorders
- (2010) Malkeet S. Bahia et al. Chemical Biology & Drug Design
- Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain
- (2010) Rishabh Dev et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- -Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
- (2010) E.-J. Lee et al. JOURNAL OF IMMUNOLOGY
- EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments
- (2009) Hiromi Kataoka JOURNAL OF DERMATOLOGICAL SCIENCE
- Matrix metalloproteinases and their multiple roles in neurodegenerative diseases
- (2009) Gary A Rosenberg LANCET NEUROLOGY
- Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia
- (2008) Moon-Sook Woo et al. JOURNAL OF NEUROCHEMISTRY
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease
- (2008) Melissa K McCoy et al. Journal of Neuroinflammation
- Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia
- (2008) E. Candelario-Jalil et al. NEUROSCIENCE
- MMPs in the central nervous system: Where the good guys go bad
- (2007) S AGRAWAL et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started